Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5222
Title: AVP-786 as a promising treatment option for Alzheimer's Disease including agitation
Authors: Khoury, Rita
Marx, Charlotte
Mirgati, Sidney
Velury, Divya
Chakkamparambil, Binu
Grossberg, George T
Affiliations: Faculty of Medicine 
Keywords: Agitation
Alzheimer’s Disease
avp-786
Deuteration
Dextromethorphan
Efficacy
Pharmacology
Quinidine
Safety
Tolerability
Issue Date: 2021
Publisher: Taylor & Francis Online
Part of: Expert Opinion on Pharmacotherapy
Volume: 22
Issue: 7
Start page: 783
End page: 795
Abstract: 
To date, there is no FDA-approved treatment for agitation in Alzheimer's disease (AD). Medications currently used off-label have modest clinical efficacy and serious side effects.
URI: https://scholarhub.balamand.edu.lb/handle/uob/5222
ISSN: 14656566
DOI: 10.1080/14656566.2021.1882995
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

SCOPUSTM   
Citations

1
checked on Jan 22, 2022

Record view(s)

4
checked on Jan 23, 2022

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.